LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2024 Earnings Guid

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.600-1.710 for the period, compared to the consensus estimate of 1.530. The company issued revenue guidance of $209.7 million-$214.3 million, compared to the consensus revenue estimate of $210.0 million. LeMaitre Vascular […]

Related Keywords

Georgew Lemaitre , , Lemaitre Vascular , Lemaitre Vascular Inc , Cubist Systematic Strategies , First Trust Advisors , Lemaitre Vascular Company Profile , Keycorp , Get Free Report , Maitre Vascular , Moderate Buy , Trust Advisors , Investment Advisers , Systematic Strategies , Quantbot Technologies , Lemaitre Vascular Daily , Nasdaq Lmat , Ilmat , Medical , Guidance , Earnings , Preannouncement ,